Michael Hanely
2021
In 2021, Michael Hanely earned a total compensation of $1.3M as Chief Operating Officer at Aeglea BioTherapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $180,000 |
|---|---|
| Salary | $380,000 |
| Stock Awards | $704,702 |
| Other | $17,417 |
| Total | $1,282,119 |
Hanely received $704.7K in stock awards, accounting for 55% of the total pay in 2021.
Hanely also received $180K in non-equity incentive plan, $380K in salary and $17.4K in other compensation.
Rankings
In 2021, Michael Hanely's compensation ranked 7,868th out of 12,406 executives tracked by ExecPay. In other words, Hanely earned more than 36.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,868 out of 12,406 | 37th |
Division Manufacturing | 3,474 out of 5,494 | 37th |
Major group Chemicals And Allied Products | 1,546 out of 2,369 | 35th |
Industry group Drugs | 1,374 out of 2,090 | 34th |
Industry Pharmaceutical Preparations | 1,017 out of 1,537 | 34th |
Source: SEC filing on April 21, 2022.
Hanely's colleagues
We found two more compensation records of executives who worked with Michael Hanely at Aeglea BioTherapeutics in 2021.